** Shares of Genetic Signatures Ltd GSS.AX rise as much as
10.6% to A$1.83, their biggest intraday pct gain since Dec 23
** Molecular diagnostics co posts a sevenfold rise in H1
total sales revenue to A$18.7 mln ($14.72 mln) urn:newsml:reuters.com:*:nASX1RKQY6
** GSS also records turnaround to profit of A$4.5 mln from a
loss of A$2.3 mln last year, driven by increased sales and
improved gross margin
** Stock hits highest since Feb 15
** GSS had fallen 17.7% this year, as of last close
($1 = 1.2700 Australian dollars)
(Reporting by Savyata Mishra in Bengaluru)
((Savyata.mishra@thomsonreuters.com))